Theromics Inc

Theromics Inc. is a small company headquartered in West Bridgewater, Massachusetts. It employs 7 people and generates annual revenue of $2.5 million. Theromics Inc. specializes in developing innovative medical technologies focused on thermal ablation procedures. Their flagship product, HeatSYNC, is a novel thermal accelerant gel designed to enhance the effectiveness of microwave, radiofrequency, or cryoablation treatments for soft tissue, fibroids, and bone. HeatSYNC operates by extending the reach of thermal energy, allowing for deeper tissue penetration without the need for high-power energy sources. This unique property makes it a valuable tool for physicians performing thermal ablation procedures. Theromics Inc. is actively researching the use of HeatSYNC as part of a groundbreaking drug delivery system in conjunction with thermal ablation. This new therapy, known as TACT (Thermally Activated Combination Therapy), holds promise for improved treatment outcomes in various medical applications. For further information, please visit their website at theromicsinc.com.